Drug Information

Drug General Information
Drug ID
D09TCY
Former ID
DNCL002548
Drug Name
CDX-1401
Indication Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] Phase 2 [524740]
Company
Celldex Therapeutics
Target and Pathway
Target(s) NY-ESO-1 Target Info Modulator [550444]
References
Ref 524740ClinicalTrials.gov (NCT02129075) CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301in Treating Patients With Stage IIB-IV Melanoma. U.S. National Institutes of Health.
Ref 550444National Cancer Institute Drug Dictionary (drug id 651880).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.